PO:12:311 Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab and between biosimilars in SLE and other connective tissue diseases and vasculitis

Ramli, R.Z., Bithell, C., Patel, M.S. et al. (4 more authors) (2026) PO:12:311 Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab and between biosimilars in SLE and other connective tissue diseases and vasculitis. [Conference abstract]

Metadata

Item Type: Conference abstract
Authors/Creators:
Dates:
  • Published (online): 1 March 2026
  • Published: 1 March 2026
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Date Deposited: 13 Mar 2026 14:50
Last Modified: 13 Mar 2026 14:50
Status: Published
Publisher: BMJ
Identification Number: 10.1136/lupus-2026-el.362
Sustainable Development Goals:
  • Sustainable Development Goals: Goal 3: Good Health and Well-Being
Open Archives Initiative ID (OAI ID):

Export

Statistics

View Altmetric information about this item.


CORE (COnnecting REpositories)